Velan Inc. Reports Solid Performance in the Third Quarter of Fiscal 2026

Core Insights - Velan Inc. reported solid performance in Q3 fiscal 2026, with a backlog of $296.8 million and bookings rising nearly 32% year over year, driven by significant contracts in the nuclear sector [4][10][8] - The company anticipates that the proposed sale of the Velan family's majority share to Birch Hill Equity Partners will create a results-oriented environment to enhance business strategy and shareholder value [4][27] - Despite higher late-stage inventory impacting working capital, the company maintains a strong balance sheet with $86 million in liquidity and a net cash position of $20.2 million [5][25] Financial Results - Q3 sales were $71.7 million, a decrease of 2.4% from $73.4 million last year, with gross profit at $27.2 million, or 37.9% of sales [6][12] - Operating income improved to $5.9 million from a loss of $62.4 million a year ago, and net income was $3.0 million, or $0.14 per share, compared to a net loss of $47.8 million, or $2.22 per share, last year [6][16] - For the nine-month period, sales totaled $211.5 million, a slight decrease from $212.0 million, with net income of $19.2 million, or $0.89 per share, compared to a net loss of $51.2 million, or $2.37 per share, in the prior year [18][23] Backlog and Bookings - The backlog increased by 8.0% since the beginning of the fiscal year, with $296.8 million as of November 30, 2025, and 80.4% of this backlog is expected to be delivered within the next 12 months [8][9] - Bookings for Q3 were $77.9 million, up from $59.1 million a year ago, reflecting higher demand in North America and international operations [10][11] - For the first nine months, bookings totaled $221.3 million, down from $230.5 million in the same period last year, primarily due to lower bookings in North America and Germany [11] Operational Highlights - Gross profit margin remained steady at 37.9%, despite lower sales volume and tariff impacts, while administration costs decreased to $16.5 million [13][14] - Adjusted EBITDA for Q3 was $9.5 million, down from $14.3 million last year, mainly due to lower gross profit and increased other expenses [15] - The company incurred restructuring expenses of $1.3 million in Q3, significantly lower than the $74.5 million from the previous year, which included substantial asbestos-related costs [14][21] Future Outlook - The company expects to conclude fiscal 2026 with solid performance, supported by a strong backlog and ongoing projects, despite uncertainties related to tariffs [26] - The completion of the proposed transaction with Birch Hill is anticipated to enhance operational capabilities and shareholder value [27][28]